COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 202 filers reported holding COHERUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $207,649 | +13.9% | 55,521 | +30.1% | 0.00% | 0.0% |
Q2 2023 | $182,273 | +63409.8% | 42,687 | +1.6% | 0.00% | -50.0% |
Q1 2023 | $287 | -1.7% | 42,004 | +14.1% | 0.00% | -33.3% |
Q4 2022 | $292 | -99.9% | 36,828 | +56.0% | 0.01% | +20.0% |
Q3 2022 | $227,000 | -82.1% | 23,610 | -86.5% | 0.01% | -84.8% |
Q2 2022 | $1,268,000 | -47.9% | 175,090 | -7.2% | 0.03% | -42.1% |
Q1 2022 | $2,436,000 | -22.2% | 188,701 | -3.8% | 0.06% | +9.6% |
Q4 2021 | $3,132,000 | +954.5% | 196,222 | +1089.9% | 0.05% | +300.0% |
Q4 2019 | $297,000 | -29.3% | 16,491 | -46.5% | 0.01% | -23.5% |
Q1 2019 | $420,000 | +61.5% | 30,809 | +58.0% | 0.02% | +142.9% |
Q3 2017 | $260,000 | -36.9% | 19,502 | -32.0% | 0.01% | -46.2% |
Q2 2017 | $412,000 | -16.1% | 28,681 | +23.5% | 0.01% | -13.3% |
Q1 2017 | $491,000 | +21.2% | 23,223 | +61.3% | 0.02% | +50.0% |
Q4 2016 | $405,000 | +41.6% | 14,396 | +34.9% | 0.01% | +42.9% |
Q3 2016 | $286,000 | +49.7% | 10,670 | -5.6% | 0.01% | +75.0% |
Q2 2016 | $191,000 | – | 11,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |